BridgeMD
New treatment option for Breast Cancer Stage I
Official title Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery
ClinicalTrials.gov ID: NCT06931548
What this study is testing
- What it's testing
- There is currently no consensus on the "gold standard" for Implant-based Breast reconstruction. In the United States, more than half of all breast reconstructions are performed using acellular dermal matrix (ADM).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- White women;
- Breast cancer stage 0-II;
- Indications for breast reconstruction;
- Consent to participate in the study and photographic documentation.
You likely can't join if
- Non-white women;
- Breast cancer stage III-IV;
- Tubular breast;
- Mental and cognitive health disorders;
- Failure to comply with recommendations in the postoperative period (premature physical activity, not wearing compression underwear, missing scheduled...
- Patient refusal to participate in the study at any stage.
The study team makes the final eligibility decision.
Where it's taking place
- Moscow, Skolkovo Innovation Center, Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Moscow, Skolkovo Innovation Center, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.